Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandeep Jassal

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Pediatrics|December 22, 2022
When there is no air, the cradle will fall: A narrative review of tobacco-related content across infant safe sleep interventionsAysha Jawed, Mandeep Jassal
International Journal of Environmental Research and Public Health|December 24, 2021
Hard to Reach or Just Not Enough? A Narrative Review of Inpatient Tobacco Cessation Programs in PediatricsAysha Jawed, Mandeep Jassal
The Lancet. Infectious Diseases|November 8, 2008
Extensively drug-resistant tuberculosisMandeep Jassal, William R Bishai
BMC Public Health|August 6, 2021
Tobacco treatment clinics in urban public housing: feasibility and outcomes of a hands-on tobacco dependence service in the communityPanagis Galiatsatos, Alexandria Soybel, Mandeep Jassal, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 24, 2025
A Randomized, Double-Blind Crossover Study of Change in Post-Dose Lung Function with Hydrofluoroolefin-1234ze, a Next-Generation Propellant for Metered Dose Inhalers, in Participants with AsthmaRoy A Pleasants, Alan S Bell, Mandeep Jassal, et al.
Clinical Therapeutics|December 4, 2025
Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a SpacerHitesh Pandya, Mehul Patel, Michael Gillen, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 16, 2024
Evaluation of a novel pediatric asthma inhalation drug delivery device: a focus on patient accessibility, ease of use, dosage feedback, and future directionsLily Zhu, Aditya Khandeshi, Maxwell A Xu, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 12, 2018
Association between second hand smoke (SHS) exposure and caregiver stress in children with poorly controlled asthmaArlene M Butz, Mona Tsoukleris, Mary Elizabeth Bollinger, et al.
Therapeutic Advances in Respiratory Disease|February 12, 2026
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studiesArtur Bednarczyk, Magnus Aurivillius, Mandeep Jassal, et al.
Eclinicalmedicine|August 20, 2025
Safety of budesonide/glycopyrronium/formoterol fumarate dihydrate delivered by HFO-1234ze versus HFA-134a in chronic obstructive pulmonary disease: a phase 3, multi-site, randomised, double-blind, parallel-group, active-comparator studyOmar S Usmani, Fernando J Martinez, Hitesh Pandya, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Pediatrics|December 22, 2022
When there is no air, the cradle will fall: A narrative review of tobacco-related content across infant safe sleep interventionsAysha Jawed, Mandeep Jassal
International Journal of Environmental Research and Public Health|December 24, 2021
Hard to Reach or Just Not Enough? A Narrative Review of Inpatient Tobacco Cessation Programs in PediatricsAysha Jawed, Mandeep Jassal
The Lancet. Infectious Diseases|November 8, 2008
Extensively drug-resistant tuberculosisMandeep Jassal, William R Bishai
BMC Public Health|August 6, 2021
Tobacco treatment clinics in urban public housing: feasibility and outcomes of a hands-on tobacco dependence service in the communityPanagis Galiatsatos, Alexandria Soybel, Mandeep Jassal, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 24, 2025
A Randomized, Double-Blind Crossover Study of Change in Post-Dose Lung Function with Hydrofluoroolefin-1234ze, a Next-Generation Propellant for Metered Dose Inhalers, in Participants with AsthmaRoy A Pleasants, Alan S Bell, Mandeep Jassal, et al.
Clinical Therapeutics|December 4, 2025
Exposure to Budesonide, Glycopyrronium, and Formoterol With a Next-Generation Propellant Does Not Exceed Exposure With Hydrofluoroalkane-134a Propellant When Administered Via Pressurized Metered-Dose Inhaler With a SpacerHitesh Pandya, Mehul Patel, Michael Gillen, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 16, 2024
Evaluation of a novel pediatric asthma inhalation drug delivery device: a focus on patient accessibility, ease of use, dosage feedback, and future directionsLily Zhu, Aditya Khandeshi, Maxwell A Xu, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 12, 2018
Association between second hand smoke (SHS) exposure and caregiver stress in children with poorly controlled asthmaArlene M Butz, Mona Tsoukleris, Mary Elizabeth Bollinger, et al.
Therapeutic Advances in Respiratory Disease|February 12, 2026
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studiesArtur Bednarczyk, Magnus Aurivillius, Mandeep Jassal, et al.
Eclinicalmedicine|August 20, 2025
Safety of budesonide/glycopyrronium/formoterol fumarate dihydrate delivered by HFO-1234ze versus HFA-134a in chronic obstructive pulmonary disease: a phase 3, multi-site, randomised, double-blind, parallel-group, active-comparator studyOmar S Usmani, Fernando J Martinez, Hitesh Pandya, et al.
Pageof 1